Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

Publisher： Karger

E-ISSN： 1423-0194|103|3-4|345-353

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.103, Iss.3-4, 2015-08, pp. : 345-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Relevance of Aberrant DNA Methylation in G1 and G2 Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 100, Iss. 1, 2014-07 ,pp. : 26-34

Karger

Access to resources Recommend Favorite

Immunohistochemical Expression and Prognostic Value of ER, PR and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 93, Iss. 4, 2011-04 ,pp. : 249-258

Karger

Access to resources Recommend Favorite

Diabetes, Smoking, Alcohol Use, and Family History of Cancer as Risk Factors for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis

By  

Neuroendocrinology, Vol. 101, Iss. 2, 2015-01 ,pp. : 133-142

Karger

Access to resources Recommend Favorite

Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2013-05 ,pp. : 347-354

Karger

Access to resources Recommend Favorite

Clinical and Prognostic Features of Rectal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 98, Iss. 3, 2013-11 ,pp. : 180-187

Karger

Access to resources Recommend Favorite